Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) ...

Craig-Hallum analyst Albert Lowe maintained a Buy rating on Eupraxia Pharmaceuticals (EPRX – Research Report) today. The company’s shares ...

The business, which provides filters for the purification of food or beverages and drugs during development, brought in about $1 billion in revenue in 2024, Thermo said. Evercore analyst Vijay ...

RXRX is expected to provide updates on its oncology and rare disease pipeline in its fourth-quarter earnings release, given ...

Citizens JMP raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $443 from $427 and keeps an Outperform rating on the shares.

Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...

the filter user will be thoroughly analyzed. PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.

Pharmaceutical facilities must accommodate ... This includes systems to prevent contamination, such as advanced ventilation and filtration, and the use of carefully selected materials resistant ...